FAGRON N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.24 EUR | +0.22% |
|
+2.24% | +9.81% |
| 04-11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
| 04-11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FAGRON N.V. | Other Pharmaceuticals | +0.22% | +2.24% | +9.81% | +8.19% | +2.93% | 1.42B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- FAGR Stock
- Charts Fagron N.V.
- Comparison Chart
